Speech-Language Pathologists in Cherryville, NC Accepting Medicare
3 Speech-Language Pathologists found. Showing 1 - 3
 Ms. Kristin Whitaker, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Harrilson Rd, Cherryville, NC 28021 Phone: 704-435-0108 |
Ms. Sandra D'ann Hill Markland, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2989 Highway 274, Cherryville, NC 28021 Phone: 704-435-1780 |
Natalie James-daniels, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 111 Harrilson Rd, Cherryville, NC 28021 Phone: 704-435-0108 Fax: 704-435-4982 |
News Archive
UCSF scientists receive CIRM grants to advance degenerative muscle disease research
Three UCSF scientists have received grants from the California Institute for Regenerative Medicine to advance their investigations of treatment strategies for degenerative muscle diseases, such as muscular dystrophy, and heart disease, and to determine why human embryonic stem cells are susceptible to forming tumors.
Fear of ruptures spurs recall of silicone breast implants in France
Breast enhancement surgery utilizes implants that are essentially bags containing silicone gel. One of the commonest complications of this procedure is the rupture of these silicone implants that may necessitate a repeat procedure. In a new development the implants made French company Poly Implant Prothese (PIP), have reportedly double the risk of rupturing than other implants. Many breast implants used by Australian women have been recalled overseas for containing unauthorised silicone gel.
Optimer third quarter net loss increases to $11.8 million
Optimer Pharmaceuticals, Inc. today reported financial results for the third quarter ended September 30, 2010. Optimer reported a net loss for the third quarter of 2010 of $11.8 million, or $0.30 per share, which was in line with the Company's expectations. This compares to a net loss for the third quarter of 2009 of $9.4 million, or $0.28 per share. The increase in net loss was primarily due to an increase in research and development and marketing expenses.
Effective interventions needed for increasing CRC screening among African-American men
Out of any other racial group, African American men have the lowest five-year survival rate for colorectal cancer (CRC).
› Verified 1 days ago
Physical Therapists
Optometrists
Speech-Language Pathologists
Chiropractors
Occupational Therapists